Biotechnology

Researchers from Stanford and the Arc Institute used artificial intelligence to design the genetic code of bacteriophages — viruses that attack bacteria — and created active viruses from them in the lab. This achievement could help in developing treatments against antibiotic-resistant bacteria, but experts warn that the improving ability of AI to design biological systems raises urgent questions...

If science extends our lives to 180 years, who exactly will the person we become be? Researchers from 300 universities have made an amazing discovery: there are topics other than the Palestinians. Also: the absurd parallel between Benjamin Netanyahu and Hitler, and the crisis in modern love songs.

After an exceptionally strong quarter, the Israeli company is raising its forecasts for 2026 and presenting dramatic clinical data for the treatment of PTSD and clinical depression, alongside a huge backlog of orders.

Remepy has raised $36 million in a Series A funding round. The startup develops hybrid drugs that combine prescription medication with AI-based therapeutic applications.

Researchers from Stanford University have achieved a scientific breakthrough by using artificial intelligence to design "from scratch" completely new viruses. The creation process utilized principles similar to those of advanced language models like ChatGPT.

New preclinical data indicate that the SIL204 treatment acts on three key mechanisms by which cancer tumors evade the immune system, strengthening the scientific basis for combination immunotherapy.

Scribe Therapeutics stock recorded a sharp jump of nearly 49% on its first day of trading following a successful IPO pricing. Global pharmaceutical giants Sanofi and Eli Lilly have allocated significant capital to invest in the company.